Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation
Authors
Keywords
Cirrhosis, Blood plasma, Inflammation, Fatty acids, Fatty liver, Liver, Liver diseases, Eicosanoids
Journal
PLoS One
Volume 14, Issue 1, Pages e0211537
Publisher
Public Library of Science (PLoS)
Online
2019-02-01
DOI
10.1371/journal.pone.0211537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease
- (2018) Jian-Hui Yan et al. MEDICINE
- Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
- (2017) Sadia Qamar Arain et al. Lipids in Health and Disease
- Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure
- (2016) Joan Clària et al. HEPATOLOGY
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation
- (2016) Kun Zhang et al. Scientific Reports
- Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK
- (2015) Christine Bernsmeier et al. GASTROENTEROLOGY
- Bioactive products formed in humans from fish oils
- (2015) Carsten Skarke et al. JOURNAL OF LIPID RESEARCH
- Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis
- (2014) Stefania Basili et al. DIGESTIVE AND LIVER DISEASE
- Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
- (2014) Rajiv Jalan et al. JOURNAL OF HEPATOLOGY
- Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2
- (2014) Alastair J O'Brien et al. NATURE MEDICINE
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
- (2013) Richard Moreau et al. GASTROENTEROLOGY
- Abnormalities in the serum phospholipids fatty acid profile in patients with alcoholic liver cirrhosis - a pilot study
- (2013) Danijela Ristić-Medić et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr−/− Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis
- (2013) Christopher M. Depner et al. JOURNAL OF NUTRITION
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
- (2010) Da Young Oh et al. CELL
- Eicosapentaenoic Acid Attenuates Progression of Hepatic Fibrosis with Inhibition of Reactive Oxygen Species Production in Rats Fed Methionine- and Choline-Deficient Diet
- (2010) Satoshi Kajikawa et al. DIGESTIVE DISEASES AND SCIENCES
- Omega-3 Fatty Acids and Inflammatory Processes
- (2010) Philip C. Calder Nutrients
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started